Insider Trading History of Oneill Alison

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Oneill Alison since 2007. This trader's CIK number is 1283882. At the time of last reporting, Oneill Alison was the Chief Medical Officer of Surface Oncology, Inc.. (stock ticker symbol SURF). Also see all insider trading activities at Surface Oncology, Inc..

Note that in the past ONEILL ALISON also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Surface Oncology, Inc. (SURF) by Oneill Alison

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2023 SURF 0 $0 7,042 $6,619 0 $0
2022 SURF 0 $0 19,272 $98,010 0 $0

Yearly summary of insider trading at Covalent Group Inc (ENCO) by Oneill Alison

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2007 ENCO 0 $0 25,100 $76,168 25,100 $55,997


Insider trading activities at 2 companies by Oneill Alison:

1. Surface Oncology, Inc. (SURF)

2. Covalent Group Inc (ENCO)

Table 1. Insider trading of Surface Oncology, Inc. (SURF) by Oneill Alison

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2023-08-01 SURF Sale 7,042 .94 6,619
2022-08-03 SURF Sale 4,463 1.72 7,676
2021-07-21 SURF Sale 14,809 6.10 90,334

Table 2. Insider trading of Covalent Group Inc (ENCO) by Oneill Alison

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2007-10-25 ENCO Option Ex 6,850 2.26 15,480
2007-10-26 ENCO Option Ex 100 2.60 260
2007-10-25 ENCO Sale 6,850 3.00 20,550
2007-10-26 ENCO Sale 100 3.10 310
2007-05-31 ENCO Option Ex 1,250 2.26 2,824
2007-05-31 ENCO Sale 1,250 3.20 4,000
2007-05-25 ENCO Option Ex 16,900 2.21 37,433
2007-05-25 ENCO Sale 16,900 3.04 51,308

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Oneill Alison (Chief Medical Officer of Surface Oncology, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.